Literature DB >> 22158540

Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.

Chen Wu1, Xiaoping Miao, Liming Huang, Xu Che, Guoliang Jiang, Dianke Yu, Xianghong Yang, Guangwen Cao, Zhibin Hu, Yongjian Zhou, Chaohui Zuo, Chunyou Wang, Xianghong Zhang, Yifeng Zhou, Xianjun Yu, Wanjin Dai, Zhaoshen Li, Hongbing Shen, Luming Liu, Yanling Chen, Sheng Zhang, Xiaoqi Wang, Kan Zhai, Jiang Chang, Yu Liu, Menghong Sun, Wei Cao, Jun Gao, Ying Ma, Xiongwei Zheng, Siu Tim Cheung, Yongfeng Jia, Jian Xu, Wen Tan, Ping Zhao, Tangchun Wu, Chengfeng Wang, Dongxin Lin.   

Abstract

Pancreatic cancer has the lowest survival rate among human cancers, and there are no effective markers for its screening and early diagnosis. To identify genetic susceptibility markers for this cancer, we carried out a genome-wide association study on 981 individuals with pancreatic cancer (cases) and 1,991 cancer-free controls of Chinese descent using 666,141 autosomal SNPs. Promising associations were replicated in an additional 2,603 pancreatic cancer cases and 2,877 controls recruited from 25 hospitals in 16 provinces or cities in China. We identified five new susceptibility loci at chromosomes 21q21.3, 5p13.1, 21q22.3, 22q13.32 and 10q26.11 (P = 2.24 × 10(-13) to P = 4.18 × 10(-10)) in addition to 13q22.1 previously reported in populations of European ancestry. These results advance our understanding of the development of pancreatic cancer and highlight potential targets for the prevention or treatment of this cancer.

Entities:  

Mesh:

Year:  2011        PMID: 22158540     DOI: 10.1038/ng.1020

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  43 in total

1.  A genome-wide association study of global gene expression.

Authors:  Anna L Dixon; Liming Liang; Miriam F Moffatt; Wei Chen; Simon Heath; Kenny C C Wong; Jenny Taylor; Edward Burnett; Ivo Gut; Martin Farrall; G Mark Lathrop; Gonçalo R Abecasis; William O C Cookson
Journal:  Nat Genet       Date:  2007-09-16       Impact factor: 38.330

2.  Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

Authors:  Adèle Hannigan; Paul Smith; Gabriela Kalna; Cristiana Lo Nigro; Clare Orange; Darren I O'Brien; Reshma Shah; Nelofer Syed; Lindsay C Spender; Blanca Herrera; Johanna K Thurlow; Laura Lattanzio; Martino Monteverde; Meghan E Maurer; Francesca M Buffa; Jelena Mann; David C K Chu; Catharine M L West; Max Patridge; Karin A Oien; Jonathan A Cooper; Margaret C Frame; Adrian L Harris; Louise Hiller; Linda J Nicholson; Milena Gasco; Tim Crook; Gareth J Inman
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

3.  Inhibition of Bach1 ameliorates indomethacin-induced intestinal injury in mice.

Authors:  A Harusato; Y Naito; T Takagi; S Yamada; K Mizushima; Y Hirai; R Horie; K Inoue; K Fukumoto; I Hirata; T Omatsu; E Kishimoto; K Uchiyama; O Handa; T Ishikawa; S Kokura; H Ichikawa; A Muto; K Igarashi; T Yoshikawa
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

Review 4.  ABO blood group and cancer.

Authors:  Simona Iodice; Patrick Maisonneuve; Edoardo Botteri; Maria Teresa Sandri; Albert B Lowenfels
Journal:  Eur J Cancer       Date:  2010-12       Impact factor: 9.162

Review 5.  Familial pancreatic cancer.

Authors:  A P Klein; R H Hruban; K A Brune; G M Petersen; M Goggins
Journal:  Cancer J       Date:  2001 Jul-Aug       Impact factor: 3.360

6.  Genome-wide association study of pancreatic cancer in Japanese population.

Authors:  Siew-Kee Low; Aya Kuchiba; Hitoshi Zembutsu; Akira Saito; Atsushi Takahashi; Michiaki Kubo; Yataro Daigo; Naoyuki Kamatani; Suenori Chiku; Hirohiko Totsuka; Sumiko Ohnami; Hiroshi Hirose; Kazuaki Shimada; Takuji Okusaka; Teruhiko Yoshida; Yusuke Nakamura; Hiromi Sakamoto
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 7.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

8.  Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.

Authors:  Dan Zhao; Dongkui Xu; Xuemei Zhang; Li Wang; Wen Tan; Yongli Guo; Dianke Yu; Hui Li; Ping Zhao; Dongxin Lin
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

9.  BACH1 is a specific repressor of HMOX1 that is inactivated by arsenite.

Authors:  John F Reichard; Maureen A Sartor; Alvaro Puga
Journal:  J Biol Chem       Date:  2008-06-11       Impact factor: 5.157

10.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Authors:  Gloria M Petersen; Laufey Amundadottir; Charles S Fuchs; Peter Kraft; Rachael Z Stolzenberg-Solomon; Kevin B Jacobs; Alan A Arslan; H Bas Bueno-de-Mesquita; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Harvey A Risch; Wei Zheng; Demetrius Albanes; William R Bamlet; Christine D Berg; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Manal Hassan; Barbara Howard; David J Hunter; Amy Hutchinson; Mazda Jenab; Rudolf Kaaks; Charles Kooperberg; Vittorio Krogh; Robert C Kurtz; Shannon M Lynch; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Hemang Parikh; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Laudina Rodriguez; Daniela Seminara; Xiao-Ou Shu; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Zhaoming Wang; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Joseph F Fraumeni; Robert N Hoover; Patricia Hartge; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

View more
  89 in total

Review 1.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

Review 2.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

4.  ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.

Authors:  Harvey A Risch; Lingeng Lu; Jing Wang; Wei Zhang; Quanxing Ni; Yu-Tang Gao; Herbert Yu
Journal:  Am J Epidemiol       Date:  2013-05-06       Impact factor: 4.897

5.  Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population.

Authors:  Pingting Ying; Yao Li; Nan Yang; Xiaoyang Wang; Haoxue Wang; Heng He; Bin Li; Xiating Peng; Danyi Zou; Ying Zhu; Rong Zhong; Xiaoping Miao; Jianbo Tian; Jiang Chang
Journal:  Arch Toxicol       Date:  2021-01-21       Impact factor: 5.153

6.  RPA-Binding Protein ETAA1 Is an ATR Activator Involved in DNA Replication Stress Response.

Authors:  Yuan-Cho Lee; Qing Zhou; Junjie Chen; Jingsong Yuan
Journal:  Curr Biol       Date:  2016-11-03       Impact factor: 10.834

7.  Genome-wide association studies: inherent limitations and future challenges.

Authors:  Yan Du; Jiaxin Xie; Wenjun Chang; Yifang Han; Guangwen Cao
Journal:  Front Med       Date:  2012-11-03       Impact factor: 4.592

8.  Identification of a shared protective genetic susceptibility locus for colorectal cancer and gastric cancer.

Authors:  Na He; Lijun Liu; Xianglong Duan; Li Wang; Dongya Yuan; Tianbo Jin; Longli Kang
Journal:  Tumour Biol       Date:  2015-09-17

9.  Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.

Authors:  B M Wolpin; E M O'Reilly; Y J Ko; L S Blaszkowsky; M Rarick; C M Rocha-Lima; P Ritch; E Chan; J Spratlin; T Macarulla; E McWhirter; D Pezet; M Lichinitser; L Roman; A Hartford; K Morrison; L Jackson; M Vincent; L Reyno; M Hidalgo
Journal:  Ann Oncol       Date:  2013-02-28       Impact factor: 32.976

10.  Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population.

Authors:  Chengli Liu; Yingjie Wang; Hui Huang; Cheng Wang; Hui Zhang; Yalin Kong; Hongyi Zhang
Journal:  Tumour Biol       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.